GET THE APP

Synthesis, molecular docking and cytotoxic study of 7-methoxy-2-(4-thiomethylphenyl)-1-benzofuran-5-carbaldehyde | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Synthesis, molecular docking and cytotoxic study of 7-methoxy-2-(4-thiomethylphenyl)-1-benzofuran-5-carbaldehyde

Author(s): Bapu R. Thorat, Ravindra Jagtap, Vaishali B. Thorat, Annasaheb Khemanar and Ramesh S. Yamgar

The 7-methoxy-2-(4-thiomethylphenyl)-1-benzofuran-5-carbaldehyde was synthesised by known literature method (Wittig reaction approach) from vanillin. To deduce the anticancer and antibacterial activity of the 7-methoxy-2-(4- thiomethylphenyl)-1-benzofuran-5-carbaldehyde, it is docked with different biomarkers of cancer cell and bacteria. Grid was generated for each oncoproteins by specifying the active site amino acids. The binding model of best scoring analogue with each protein was assessed from their G-scores and disclosed by docking analysis using the XP visualizer tool. An analysis of the receptor-ligand interaction studies revealed that 7-methoxy-2-(4- thiomethylphenyl)-1-benzofuran-5-carbaldehyde is most active against 1BAG and 4FNY biomarkers and have the features to prove themselves as anticancer drugs. It shows strong cytotoxicity against human cell line [lung (A-459) and breast (MCF-07)].


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 23677

Der Pharma Chemica received 23677 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry